Morgan Stanley’s TScan Therapeutics TCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.24M | Buy |
|
|||||
|
2025
Q1 | $818K | Buy |
|
|||||
|
2024
Q4 | $1.26M | Buy |
|
|||||
|
2024
Q3 | $1.49M | Buy |
|
|||||
|
2024
Q2 | $1.41M | Buy |
|
|||||
|
2024
Q1 | $1.78M | Sell |
|
|||||
|
2023
Q4 | $2.74M | Buy |
|
|||||
|
2023
Q3 | $664K | Buy |
|
|||||
|
2023
Q2 | $271K | Sell |
|
|||||
|
2023
Q1 | $276K | Buy |
|
|||||
|
2022
Q4 | $65.4K | Sell |
|
|||||
|
2022
Q3 | $197K | Buy |
|
|||||
|
2022
Q2 | $180K | Buy |
|
|||||
|
2022
Q1 | $110K | Buy |
|
|||||
|
2021
Q4 | $123K | Sell |
|
|||||
|
2021
Q3 | $235K | Buy |
|